| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/08/2004 | EP0986370B1 Cosmetic product containing plant extracts |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527729A Topical pharmaceutical formulation |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527706A Pharmaceutical compositions containing terbinafin and use thereof |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
| 09/08/2004 | CN1526447A Human blood vessel IBP sample growth factor |
| 09/08/2004 | CN1526414A Hair restoring capsule |
| 09/08/2004 | CN1526410A Medicine liquid for treating skin disease |
| 09/08/2004 | CN1526406A Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/08/2004 | CN1165299C Composition for treatment of psoriasis |
| 09/08/2004 | CN1165286C Personal wash liquid composition comprising low viscosity oils pre-thickened by nno-antifoaming hydrophobic polymers |
| 09/08/2004 | CN1165283C Cosmetic cleansing and skin care preparation containing plant and algae extracts |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787529 Synergistic mixture of vitamin d and corticosteroids; skin disorders |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787161 Anti-cancer compounds |
| 09/07/2004 | US6787160 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 09/07/2004 | US6787152 Balancing the molecular properties (van der waals forces and dipole moments) of all the components against those of all the components plus the particular active agent. |
| 09/07/2004 | US6787148 Chemical peeling agent |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | CA2311510C Skin care composition |
| 09/07/2004 | CA2166898C Novel structural analogues of vitamin d |
| 09/02/2004 | WO2004074304A1 Compound, process for producing the same and use thereof |
| 09/02/2004 | WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 09/02/2004 | WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same |
| 09/02/2004 | WO2004073743A2 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions |
| 09/02/2004 | WO2004073731A1 14-3-3 protein for prevention and treatment of fibroproliferative disorders |
| 09/02/2004 | WO2004073723A1 Medical drug containing fine particle of noble metal |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | WO2004073713A1 Pirfenidone gel preparation |
| 09/02/2004 | WO2004073707A1 Topical composition containing alkyl gallate or alkyl hydroxybenzoate or phenol alkyloxy as agent against acne |
| 09/02/2004 | WO2004073680A1 Ointment of droplet-dispersion type |
| 09/02/2004 | WO2004073677A1 Therapeutic agent angiogen |
| 09/02/2004 | WO2004073674A1 Tea-tree oil-based preparation, methods for the production and use thereof |
| 09/02/2004 | WO2004073597A2 Bioadhesive liquid composition which is substancially free of water |
| 09/02/2004 | WO2004073595A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | WO2004073593A2 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
| 09/02/2004 | WO2004037187A3 Metal-containing materials, compositions and methods |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003037933A3 Dermopharmaceutically and cosmetically active oligopeptides |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171695 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171647 Reducing adverse side effects using optically pure S form |
| 09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171599 Use of a pharmaceutically acceptable cellulose derivative to inhibit or reduce crystal growth of ascomycin |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171590 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171578 in particular of inflammatory and hyperproliferative skin diseases, and cutaneous manifestations of immunologically induced diseases |
| 09/02/2004 | US20040171561 storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or a pharmaceutically acceptable salt or ester thereof, and a pharmaceutically acceptable carrier |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171534 chimeric analogs include a hydrophobic moiety (tail), and can be prepared, either by anchoring one or several hydrophobic tails to the GRF, or by substituting one or several amino-acids by a pseudomicellar residue in the chemical synthesis of GRF |
| 09/02/2004 | US20040171530 Polypeptides containing cysteine and tryptophan |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170997 used in drug screening for preventing or treating diseases associated with abnormalities in intracellular signal transduction; genetic engineering |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170969 GRF2 binding proteins and applications thereof |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170702 Method and composition for treating hypopigmentation of the hair and skin |
| 09/02/2004 | US20040170655 preserving normal sebum homeostasis; prophylaxis and treatment of greasy hair and dandruff; prophylaxis and treatment of mild forms of acne, and for the prophylaxis and control of seborrhea and blemished skin. |
| 09/02/2004 | US20040170635 administering an inhibitor of the CD2/LFA-3 interaction, in combination with narrow band UVB radiation; especially for treating psoriasis |
| 09/02/2004 | US20040170623 having a concentration of at least 50 mg/ml of the antibody and containing an acidic component; nasal sprays and slow release formulations drying or freeze-drying |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
| 09/02/2004 | US20040170594 Mixture of salt, lemon juice, onion juice, perfume, citric acid and alcohol |
| 09/02/2004 | US20040170591 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 09/02/2004 | US20040170588 Polyethersiloxane copolymer in aqueous solution |
| 09/02/2004 | US20040170585 Skin disorders |
| 09/02/2004 | DE10307388A1 Glyzyrrhetinsäureester Glyzyrrhetinsäureester |
| 09/02/2004 | DE10306987A1 Zubereitung auf Basis von Teebaumöl sowie Verfahren zu ihrer Herstellung und ihre Verwendung Preparation on the basis of tea tree oil and processes for their preparation and their use |
| 09/02/2004 | DE10253129A1 Wound healing or skin-care agent for treating skin defects or burns contains sea buckthorn oil, St. John's wort oil, propolis and 'Mumie' |
| 09/02/2004 | CA2518313A1 Medicament comprising noble metal fineparticles |